RNA Stabilization Buffer Composition for Room-Temperature Storage

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Biological samples, particularly RNA within them, degrade over time, especially when stored at room temperature or subjected to thermal excursions, necessitating specialized equipment and processes that can damage the samples.

Innovation Solution

A stabilization buffer comprising guanidine hydrochloride, TRITON X-100, EDTA, citric acid, and sodium citrate at specific concentrations, maintaining a pH less than 4.5, effectively stabilizes biological samples, including RNA, at room temperature for extended periods.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If biological samples are stored at room temperature for extended periods, then storage convenience is improved, but RNA degradation increases

Engineering Contradiction:
Improvestorage convenienceVSAvoidRNA integrity
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The stabilization buffer is prepared in advance with optimal concentrations of guanidine hydrochloride (4.05-4.95 M), TRITON X-100 (0.09-0.11% v/v), and EDTA (18-22 mM), adjusted to pH less than 4.5, and placed in collection tubes before sample arrival. This preliminary preparation ensures immediate RNA protection upon sample collection, eliminating the need for subsequent processing steps and enabling straightforward room temperature storage while maintaining RNA integrity.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If snap-freezing reagents and super-low temperature freezers are used, then RNA degradation is prevented, but sample damage and equipment complexity increase

Engineering Contradiction:
ImproveRNA stabilityVSAvoidequipment requirements
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent replaces the mechanical cooling system (freezers at -80°C) with a chemical stabilization system. The stabilization buffer containing guanidine hydrochloride, TRITON X-100, and EDTA at pH less than 4.5 chemically prevents RNA degradation through denaturation and chelation mechanisms, eliminating the need for super-low temperature equipment while maintaining RNA stability during storage and transport.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Duration of action of stationary object

If freezing process is applied to preserve samples, then long-term storage is achieved, but biological sample damage occurs

Engineering Contradiction:
Improvestorage durationVSAvoidsample damage
Core Design Contradiction:
Duration of action of stationary objectVSObject-affected harmful factors

Solution Approach 1:

The patent converts the potentially harmful freezing process into a beneficial chemical stabilization process. By using the stabilization buffer with specific concentrations of guanidine hydrochloride, TRITON X-100, and EDTA at pH less than 4.5, the sample can be stored at room temperature for extended periods without the mechanical stress of freezing and thawing, thereby preventing sample damage while achieving long-term storage durability.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The stabilization buffer maintains RNA integrity, with minimal degradation, allowing for accurate RNA expression analysis even after incubation at room temperature for up to a day, facilitating diagnostic and research applications.

Implementation Method 1

guanidine hydrochloride at a concentration of about 4.05 M to about 4.95 M

Methodology Applied
Scientific EffectChaotropic agent action:

Implementation Method 2

EDTA at a concentration of about 18 mM to about 22 mM

Methodology Applied
Scientific EffectChelation:

Implementation Method 3

TRITONTM X-100 at a concentration of about 0.09% to about 0.11% (v/v)

Methodology Applied
Scientific EffectSurfactant action: Surfactant

Implementation Method 4

wherein the pH of the stabilization buffers is less than about 4.5

Methodology Applied
Scientific EffectpH control:

Data Source

PatentUS20250327118A1Compositions, methods and kits for biological sample and RNA stabilization
Publication Date: 2025.10.23 LIQUID BIOPSY RES LLC
  • US20250327118A1 patent drawing
  • US20250327118A1 patent drawing
  • US20250327118A1 patent drawing

AI summary

The present disclosure provides a buffer comprising at least one chaotropic agent, at least one chelating agent and at least one non-ionic surfactant, wherein the buffer stabilizes a biological sample at about room temperature for at least about one day.